Park Avenue Securities LLC Horizon Therapeutics Public LTD CO Transaction History

Park Avenue Securities LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	SELL	$62.39 - $113.8 $37,808 - $68,962	-606 Reduced 5.24%	10,956 $0
Q3 2022 Nov 01, 2022	SELL	$58.92 - $84.67 $101,637 - $146,055	-1,725 Reduced 12.98%	11,562 $715,000
Q2 2022 Jul 27, 2022	BUY	$79.4 - $116.36 $296,162 - $434,022	3,730 Added 39.03%	13,287 $1.06 Million
Q1 2022 Apr 29, 2022	SELL	$86.42 - $109.81 $172,494 - $219,180	-1,996 Reduced 17.28%	9,557 $1.01 Million
Q4 2021 Apr 08, 2022	BUY	$98.56 - $119.91 $273,996 - $333,349	2,780 Added 31.69%	11,553 $1.24 Million
Q3 2021 Oct 21, 2021	BUY	$91.91 - $110.37 $41,267 - $49,556	449 Added 5.39%	8,773 $961,000
Q2 2021 Aug 05, 2021	SELL	$86.24 - $95.92 $34,840 - $38,751	-404 Reduced 4.63%	8,324 $779,000
Q1 2021 Apr 28, 2021	BUY	$71.83 - $95.48 $272,810 - $362,633	3,798 Added 77.04%	8,728 $803,000
Q4 2020 Jan 20, 2021	BUY	$67.0 - $84.39 $100,366 - $126,416	1,498 Added 43.65%	4,930 $361,000
Q3 2020 Nov 03, 2020	SELL	$55.23 - $79.93 $27,670 - $40,044	-501 Reduced 12.74%	3,432 $267,000
Q2 2020 Jul 30, 2020	BUY	$30.2 - $56.98 $118,776 - $224,102	3,933 New	3,933 $219,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Park Avenue Securities LLC with notifications on news.